EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice

Michela De Bellis, Giuseppe d'Orsi, Egidio Maria Rubino, Claudia Arigliano, Massimo Carella, Vittorio Sciruicchio, Antonella Liantonio, Annamaria De Luca, Paola Imbrici

Frontiers in Pharmacology · 10.07.2025 · 16

DOI: 10.3389/fphar.2025.1584566 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 10.07.2025. Verfasst von Michela De Bellis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy - Drug Sciences, University of Bari "Aldo Moro", Bari, Italy. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy is a chronic and debilitating neurological disorder characterized by the occurrence of spontaneous and recurrent seizures. Despite the availability of several antiseizure medications (ASMs), people with epilepsy often experience drug resistance and adverse effects. This narrative review provides an overview of the main adverse drug reactions (ADR) caused by ASMs, including neurological, metabolic, skin reactions and drug failure, and of the underlying molecular mechanisms. Given the critical contribution of pharmacogenomics and drug-drug interactions to the occurrence of some ADRs, we provide examples of the role of major allelic variations identified in genes encoding for molecules involved in the pharmacokinetics, pharmacodynamics and immune system and emphasize the activity of ASMs as inhibitors or inducers of metabolic enzymes. Improved knowledge of the benefit-risk profile of drugs, also through enhanced pharmacovigilance activity and following guidelines recommendations, could implement patients care avoiding ADRs and favoring a beneficial personalized medicine particularly in vulnerable patients as children, elderly people and pregnant women.

Schlagwörter

Stichwörter der Autor:innen

adverse drug reactionsantiseizure medicationsdrug interactionsepilepsypharmacogenetics

Autor:innen und Institutionen

  • Department of Pharmacy - Drug Sciences, University of Bari "Aldo Moro", Bari, Italy.
  • Neurology Unit, Epilepsy Center, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy.
  • Children Epilepsy and EEG Center, San Paolo Hospital, Bari, Italy.

Zitieren

APA

De Bellis, M., d'Orsi, G., Rubino, E. M., Arigliano, C., Carella, M., Sciruicchio, V., Liantonio, A., De Luca, A., & Imbrici, P. (2025). Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1584566

Vancouver

De Bellis M, d'Orsi G, Rubino EM, Arigliano C, Carella M, Sciruicchio V, et al. Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1584566

BibTeX
@article{DeBellis2025,
  author = {De Bellis, Michela and d'Orsi, Giuseppe and Rubino, Egidio Maria and Arigliano, Claudia and Carella, Massimo and Sciruicchio, Vittorio and Liantonio, Antonella and De Luca, Annamaria and Imbrici, Paola},
  title = {Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1584566}
}
Kostenlos starten →